Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
14.28
+0.93 (6.97%)
Apr 15, 2026, 11:12 AM EDT - Market open
TNXP Employees
Tonix Pharmaceuticals Holding had 142 employees as of December 31, 2025. The number of employees increased by 61 or 75.31% compared to the previous year.
Employees
142
Change (1Y)
61
Growth (1Y)
75.31%
Revenue / Employee
$92,303
Profits / Employee
-$873,387
Market Cap
202.85M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 142 | 61 | 75.31% |
| Dec 31, 2024 | 81 | -22 | -21.36% |
| Dec 31, 2023 | 103 | -14 | -11.97% |
| Dec 31, 2022 | 117 | 44 | 60.27% |
| Dec 31, 2021 | 73 | 47 | 180.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Employee RankingsTNXP News
- 4 hours ago - Tonix Pharmaceuticals Announces Publication of Steady-State Pharmacokinetics of TONMYA® After 20 Days of Daily Dosing in the Peer-Reviewed Journal, Clinical Pharmacology in Drug Development - GlobeNewsWire
- 15 days ago - Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026 - GlobeNewsWire
- 20 days ago - Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain - GlobeNewsWire
- 22 days ago - Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026 - GlobeNewsWire
- 27 days ago - Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026 - GlobeNewsWire
- 4 weeks ago - Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026 - GlobeNewsWire
- 4 weeks ago - Tonix Pharmaceuticals Says Prescriptions For Chronic Pain Drug Top 4,200 Since Launch - Benzinga
- 4 weeks ago - Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights - GlobeNewsWire